Company: INDP
Filing Date: 2025-06-13
Form Type: PRE 14A
Source: 0001641172-25-014978
Chunk: 19

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-06-13
Form: PRE 14A
Chunk 19
---
) | Consists of 182,000 shares of common stock issuable upon exercise 
 of outstanding options.                                           |

| (13) | Consists of 58,750 shares of common stock issuable upon exercise 
 of outstanding options.                                          |

| (14) | Consists of 32,500 shares of common stock issuable upon exercise 
 of outstanding options.                                          |

| (15) | Consists of (i) 1,572,035 shares of common stock, (ii) 127,485 shares                         
 of common stock issuable upon exercise of warrants, and (ii) 2,102,616 shares of common stock 
 issuable upon exercise of outstanding options, of which 53,875 will vest within 60 days of    
 June 12, 2025.                                                                                |

<div align='center'>12

OTHER MATTERS</div>

Our Board of Directors is not aware of any matter
to be presented for action at the Special Meeting other than the matters referred to above and does not intend to bring any other matters
before the Special Meeting. However, if other matters should come before the Special Meeting, it is intended that holders of the proxies
named on the Company’s proxy card will vote thereon in their discretion.

<div align='center'>13

SOLICITATION OF PROXIES</div>

The accompanying proxy is solicited by and on
behalf of our Board of Directors, whose Notice of Special Meeting is attached to this proxy statement, and the entire cost of our solicitation
will be borne by us. In addition to the use of mail, proxies may be solicited by personal interview, telephone, e-mail and facsimile
by our directors, officers and other employees who will not be specially compensated for these services. We will also request that brokers,
nominees, custodians and other fiduciaries forward soliciting materials to the beneficial owners of shares held by the brokers, nominees,
custodians and other fiduciaries. We will reimburse these persons for their reasonable expenses in connection with these activities.

Certain information contained in this proxy statement
relating to the occupations and security holdings of our directors and officers is based upon information received from the individual
directors and officers.

<div align='center'>14</div>

WHETHER OR NOT YOU PLAN TO ATTEND THE SPECIAL MEETING IN PERSON, WE URGE YOU TO VOTE YOUR SHARES VIA THE TOLL-FREE TELEPHONE NUMBER OR OVER THE INTERNET, AS DESCR